Search results
What Is Beta Thalassemia?
Health via Yahoo News· 5 months agoBeta thalassemia is a blood disorder affecting the production of hemoglobin, the iron-rich protein in red blood cells that carries oxygen through the...
Understanding the Beta Thalassemia Minor Trait
Verywell Health via Yahoo News· 10 months agoBeta thalassemia minor—also known as beta thalassemia trait or B thalassemia—is a blood disorder. It lowers your blood's level of hemoglobin, an...
Column: This life-saving drug will cost a record $2.8 million. Who will pay the price?
LA Times via Yahoo Finance· 2 years agoA nurse sets up an IV line. A number of genetics-based treatments are expected to wash up on...
FDA approves $2.8m gene therapy treatment for rare blood disorder
The Hill via AOL· 2 years agoThe Food and Drug Administration (FDA) on Wednesday approved the first gene therapy treatment that...
3 Reasons to Buy CRISPR Therapeutics Stock Like There's No Tomorrow
Motley Fool via Yahoo Finance· 6 months agoCRISPR Therapeutics (NASDAQ: CRSP) has climbed more than 60% this year -- and for good reason. The...
Here Are the New Drugs and Treatments We Could See in 2024
Time via Yahoo News· 6 months agoCredit - Getty Images 2023 was a strong year for innovative new drugs, with new medications for...
Can This Experimental Gene Therapy Be Enough to Lift Editas Medicine in the Future?
Motley Fool· 1 year agoEditas Medicine (NASDAQ: EDIT) sits at the bleeding edge of biotech's hottest field, gene editing to...
Hemochromatosis (Iron Overload): What to Know
Verywell Health via Yahoo News· 3 months agoA condition that causes excess iron accumulation in the body Medically reviewed by Benjamin Leach, MD Hemochromatosis is a medical condition where people...
What Is Jaundice (Icterus)?
Health via Yahoo News· 2 months agoDaria Kulkova / Getty Images Medically reviewed by Robert Burakoff, MD Jaundice (also known as icterus) is a condition that causes the skin and sclera...
These 2 Stocks Are Heading for a Big Moment. Time to Buy?
Motley Fool· 11 months agoVertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) both are approaching a...